Alkermes: SEC declares Form 10 registration statement filed by Mural effective

Alkermes announced that the Registration Statement on Form 10, as amended filed by Mural Oncology Mural Oncology was declared effective by the U.S. Securities and Exchange Commission SEC . This Form 10 describes Alkermes’ planned separation of its oncology business into Mural Oncology, which, upon completion of the separation, will be a new, independent, publicly traded company. The completion of the separation is set to occur on Nov. 15 through a distribution to Alkermes shareholders of one ordinary share of Mural Oncology for every 10 ordinary shares of Alkermes held as of the close of business on Nov. 6 the record date for the distribution. No action is required by Alkermes shareholders in order to receive ordinary shares of Mural Oncology in the distribution. The completion of the separation is subject to certain conditions described in the Form 10, including those conditions set forth in a separation agreement to be entered into between Alkermes and Mural Oncology, a form of which is filed as an exhibit to the Form 10.